Evidence map›Paper›PMID 31638909›Full record

ArticleBMC geriatrics2019

Polypharmacy in older patients: identifying the need for support by a community pharmacist.

Jean-Baptiste Beuscart, Ségolène Petit, Sophie Gautier, Patrick Wierre, Thibaut Balcaen, Jean-Marc Lefebvre, Nicolas Kambia, Elisabeth Bertoux, Daniel Mascaut, Christine Barthélémy and 3 more

Registry-linked trialAbstract read
In one paragraph

Article in BMC geriatrics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05297461 (Impact of Community Pharmacists' Medication Review on Medication Use Related Problems Among Older Adults in Penang), which is not on this map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05297461 nacompletednot on this mapstarted 2022, after this paper: background citation

Impact of Community Pharmacists' Medication Review on Medication Use Related Problems Among Older Adults in Penang: A Pilot Randomised Controlled Study

TypeinterventionalSponsorMonash University MalaysiaRan2022 to 2023Enrolled27ConditionsAgingArmsMedication review
3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Jean-Baptiste BeuscartUniversity of Lille, EA 2694 - Santé publique: épidémiologie et qualité des soins, F-59000, Lille, France. jean-baptiste.beuscart@univ-lille2.fr.ORCID 0000-0002-0734-8371
Ségolène PetitDepartment of Pharmacy, CHU Lille, F-59000, Lille, France.
Sophie GautierDepartment of Pharmacology, CHU Lille, F-59000, Lille, France.
Patrick WierreAssociation des Conseillers et des Pharmaciens Agréés Maîtres de stage du Nord Pas de Calais, Lille, France.
Thibaut BalcaenUniversity of Lille, EA 2694 - Santé publique: épidémiologie et qualité des soins, F-59000, Lille, France.
Jean-Marc LefebvreDepartment of General Practice, University of Lille, F-50045, Lille Cedex, France.
Nicolas KambiaUniversity of Lille, EA 7365 - Groupe de recherche sur les injectables et les technologies associées, F-59000, Lille, France.
Elisabeth BertouxAssociation des Conseillers et des Pharmaciens Agréés Maîtres de stage du Nord Pas de Calais, Lille, France.
Daniel MascautAssociation des Conseillers et des Pharmaciens Agréés Maîtres de stage du Nord Pas de Calais, Lille, France.
Christine BarthélémyUniversity of Lille, EA 7365 - Groupe de recherche sur les injectables et les technologies associées, F-59000, Lille, France.
Damien CunyUniversity of Lille, EA 4483, Impacts de l'environnement chimique sur la santé humaine (IMPECS), F- 59000, Lille, France.
François PuisieuxUniversity of Lille, EA 2694 - Santé publique: épidémiologie et qualité des soins, F-59000, Lille, France.
Bertrand DécaudinDepartment of Pharmacy, CHU Lille, F-59000, Lille, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe community pharmacist is a key player in medication reviews of older outpatients. However, it is not always clear which individuals require a medication review. The objective of the present study was to identify high-priority older patients for intervention by a community pharmacist.

methodsAs part of their final-year placement in a community pharmacy, pharmacy students conducted 10 interviews each with older adults (aged 65 or over) taking at least five medications daily. The student interviewer also offered to examine the patient's home medicine cabinet. An interview guide was developed by an expert group to assess the difficulties in managing and taking medications encountered by older patients.

resultsThe 141 students interviewed a total of 1370 patients (mean age: 81.5; mean number of medications taken daily: 9.3). Of the 1370 interviews, 743 (54.2%) were performed in the patient's home, and thus also included an examination of the home medicine cabinet. Adverse events were reported by 566 (42.0%) patients. A total of 378 patients (27.6%) reported difficulties in preparing, administering and/or swallowing medications. The inspections of medicine cabinets identified a variety of shortcomings: poorly located cabinets (in 15.0% of inspections), medication storage problems (21.7%), expired medications (40.7%), potentially inappropriate medications (15.0%), several different generic versions of the same drug (19.9%), and redundant medications (20.4%).

conclusionsIn a community pharmacy setting, high-priority older patients for intervention by a community pharmacist can be identified by asking simple questions about difficulties in managing, administering, taking or storing medications.

Indexed as

PolypharmacyAgedAged, 80 and overCommunity Pharmacy ServicesCross-Sectional StudiesFemaleFranceHumansMaleMedication ReconciliationPharmacistsPotentially Inappropriate Medication List

Identifiers

PMID31638909
PMCPMC6802481

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.